Benchmarking the Pharma Industry’s HEOR Function (2nd Edition)

Report Overview

Health Economics and Outcomes Research (HEOR) is becoming increasingly critical in obtaining favorable reimbursement from payers around the globe. As new study types are introduced and expected, as regulations become tighter, as nods from payers become more difficult to obtain, the HEOR function must adapt accordingly. And it must adapt quickly to best serve the needs of both internal and external stakeholders. Industry Standard Research conducted qualitative research around the HEOR function in 2013 and, given the pace of change in this area, it is high time to revisit this topic to provide the latest thinking and trends to our readers.

What you will learn:

ISR has designed this report to be used as a benchmarking tool for companies to compare their HEOR functions to those of other pharmaceutical organizations.

• Determine where your company’s approach to the HEOR function may be different from a typical industry approach and the benefits and drawbacks that may result.
• Gather information on HEOR structures and headcounts employed by other organizations to provide a new perspective from which to consider your departmental alignment.
• Learn about common industry approaches to practices such as outsourcing and effectiveness measures within HEOR.
• Understand how Top 50 pharmaceutical companies are using real-world data/real-world evidence, the challenges presented by these data, and methods they use to deal with these challenges.

Major Topics:

• HEOR Employees
• HEOR and the Product Development Process
• HEOR Studies
• HEOR Department Size and Structure
• HEOR’s Effectiveness Measured
• HEOR Outsourcing
• Main Challenges Incurred by HEOR & Potential Solutions
• HEOR Budgets & Funding
• Moving Forward: HEOR over the Next 5 Years
• HEOR Best Practices
• Recommendations